Yes, Mr. Chair.
The text, as amended, would read as follows:
That the committee recognizes that due to a variety of factors, the government has faced delays in the supply of vaccines for Canadians through national manufacturing and international procurement, Canada is the only G7 country accessing vaccines through COVAX, an initiative intended to provide vaccines to high risk individuals in low and middle income countries. These supply difficulties accentuate the vulnerabilities of Canadians to dangerous variants and extends the detrimental global economic impacts of COVID-19 by delaying vaccinations to high-risk people in poor countries. Finally, that the Minister of International Development be invited to discuss this issue with the Members of the Committee.